Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aster tataricus (Tatarian aster) is a perennial herb whose roots and rhizomes, known as Zi Wan in Traditional Chinese Medicine (TCM), are traditionally used for their antitussive and expectorant properties. In the context of recent clinical research, it is being evaluated as an adjunct therapy for functional constipation. A Phase 0 clinical trial sponsored by Guangzhou Panyu Hexian Memorial Hospital is investigating whether adding Aster tataricus and Raphani Semen to the traditional Maziren Decoction improves symptoms compared to the decoction alone. The plant contains various bioactive compounds, including triterpenoid saponins (asterosaponins), cyclic peptides (astins), and flavonoids, which are thought to contribute to its pharmacological effects on respiratory and gastrointestinal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aster tataricus.